Hypogonadism Completed Phase 1 Trials for Testosterone (DB00624)

IndicationStatusPhase
DBCOND0009256 (Hypogonadism)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01378299CYP19A1 (Cytochrome P450 Family 19 Subfamily A Member 1) Gene and Pharmacogenetics of Response to Testosterone TherapyOther
NCT01133548Pharmacokinetic and Comparative Bioavailability Study of Testosterone Absorption After Administration of Testosterone Gel 1.62% to the Upper Arms/Shoulders Using an Application Site Rotation or a Combination of Application Sites in Hypogonadal MalesTreatment
NCT00161486The Effects of Testosterone on Prostate Tissue (ACYP-1)Treatment
NCT00400335Study On Bioavailability And Pharmacokinetics Of Various Doses Of Testosterone Administered With And Without DutasterideTreatment
NCT00431197Steady-State Feedback Actions of Testosterone on Luteinizing Hormone Secretion in Young and Older Men
NCT00663793ORAL T-6: Oral Androgens in Man-6Treatment
NCT00957528Cycled Testosterone Replacement StudyPrevention
NCT00998933Study of Serum Testosterone Levels in Non-dosed Females After Secondary ExposureTreatment
NCT01104246Dose Titration Investigation of the Pharmacokinetics of Testosterone Transdermal Systems in Hypogonadal MenTreatment